سوق زراعة القرنية في أمريكا الشمالية – اتجاهات الصناعة والتوقعات حتى عام 2031

تحليل وحجم سوق زراعة القرنية في أمريكا الشمالية

إن سوق زراعة القرنية في أمريكا الشمالية مدفوع بعدة عوامل، بما في ذلك الانتشار المتزايد لأمراض القرنية، وتزايد عدد السكان المسنين، والتقدم في التكنولوجيا، وزيادة الطلب على الإجراءات الأقل توغلاً، والوعي المتزايد بزراعة القرنية، والمبادرات الحكومية والتمويل، والاعتماد المتزايد على العدسات الهجينة والتوريكية، والشعبية المتزايدة لإجراءات الربط المتقاطع، وتوسع المؤشرات لزراعة القرنية، والمنافسة التي تعزز الابتكار. تعمل هذه العوامل مجتمعة على دفع الطلب على زراعة القرنية، وخاصة في البلدان المتقدمة، حيث يسعى المرضى إلى علاجات فعالة لاضطرابات الرؤية والحالات مثل القرنية المخروطية، وخلل التنسج الفقاعي، واعتلال القرنية الفقاعي الكاذب.

تحلل شركة Data Bridge Market Research أن سوق زراعة القرنية في أمريكا الشمالية من المتوقع أن يصل إلى 335.35 مليون دولار أمريكي بحلول عام 2031 من 207.02 مليون دولار أمريكي في عام 2023، وينمو بمعدل نمو سنوي مركب قدره 6.2٪ في الفترة المتوقعة من 2024 إلى 2031.

تعريف السوق

يشير سوق زراعة القرنية إلى المجال الطبي الذي يركز على الإجراءات الجراحية التي تحل محل القرنية التالفة أو المريضة بأنسجة متبرع سليمة. تُجرى عمليات زراعة القرنية، المعروفة أيضًا باسم عملية رأب القرنية، لاستعادة الرؤية لدى المرضى الذين يعانون من حالات مثل القرنية المخروطية أو ندبات القرنية أو العدوى أو خلل بطانة القرنية. يشمل السوق أنواعًا مختلفة من إجراءات زراعة القرنية، بما في ذلك عملية رأب القرنية النافذ (زرع القرنية بسمك كامل) وزرع القرنية البطانية (زرع جزئي السمك)، ويدعمها التقدم في التقنيات الجراحية وتوافر أنسجة المتبرع والرعاية المحسنة بعد الجراحة. مع انتشار اضطرابات العين على مستوى العالم، ومع الابتكارات التكنولوجية التي تعزز معدل نجاح العمليات الجراحية، يستمر سوق زراعة القرنية في النمو، مما يلبي الطلب المتزايد على استعادة الرؤية.

ديناميكيات سوق زراعة القرنية في أمريكا الشمالية:

يتناول هذا القسم فهم محركات السوق والمزايا والفرص والقيود والتحديات. ويتم مناقشة كل هذا بالتفصيل على النحو التالي:

السائقين

• تزايد انتشار أمراض العيون

إن الانتشار المتزايد لأمراض العيون هو محرك مهم في سوق زراعة القرنية في أمريكا الشمالية، حيث أصبحت حالات مثل القرنية المخروطية، وخلل بطانة الأوعية الدموية فوكس، وتندب القرنية بسبب العدوى أو الصدمات أكثر شيوعًا. يمكن أن تؤدي هذه الأمراض إلى ضعف شديد في الرؤية أو العمى، مما يدفع إلى زيادة الطلب على عمليات زرع القرنية كعلاج ترميمي. غالبًا ما يرتبط ارتفاع اضطرابات العين بعوامل مثل الشيخوخة السكانية، وارتفاع معدلات الإصابة بمرض السكري، وزيادة التعرض للملوثات البيئية والأشعة فوق البنفسجية، والتي يمكن أن تلحق الضرر بالقرنية. كما أن التقدم في تقنيات التشخيص يؤدي إلى الكشف المبكر عن هذه الأمراض، مما يسمح بالتدخلات في الوقت المناسب، بما في ذلك زراعة القرنية. علاوة على ذلك، يساهم الوعي المتزايد بصحة القرنية وتوافر التقنيات الجراحية المحسنة، مثل عملية زراعة القرنية باستخدام غشاء ديسميه (DMEK) وعملية زراعة القرنية باستخدام غشاء ديسميه الآلي (DSAEK)، في القبول المتزايد لعمليات زراعة القرنية. مع استمرار نمو عبء أمراض العيون في جميع أنحاء العالم، من المتوقع أن ترتفع الحاجة إلى حلول فعالة مثل عمليات زرع القرنية، مما يؤدي إلى تغذية نمو السوق.

على سبيل المثال،

• In June 2023, according to the article published in NCBI, a study was conducted to investigate the prevalence of keratoconus in a large German cohort and to evaluate possible associated factors. Keratoconus appears to be a rare corneal disease with a prevalence previously estimated at 1:2000. However, in recent relatively small studies, a higher prevalence was found. Prevalence is reported from 1: 6000 for US citizens, 1:1000 for Israeli adolescents, up to 1:20 for Saudi-Arabian Children. Newer studies detected prevalence estimates of 1:191 in New Zealand high school students. A prevalence of up to 1:84 was detected for young Australian adults. The prevalence of keratoconus treatment in the German population is approximately tenfold higher than previously reported in the literature using the latest technologies, namely Scheimpflug imaging, which act as a driver in the growth of the market.

Rising Geriatric Population

The rising geriatric population is a key driver in the North America corneal transplant market, as older adults are more susceptible to various eye conditions that can lead to corneal damage and the need for transplants. Age-related eye diseases, such as Fuchs' endothelial dystrophy, bullous keratopathy, and other degenerative corneal disorders, become more prevalent with advancing age, significantly increasing the demand for corneal transplants. Also, older adults are more likely to experience complications from cataract surgery or develop chronic conditions like diabetes, which can further contribute to corneal deterioration. As the North America population ages, the number of individuals requiring corneal transplants is expected to rise, particularly in regions with rapidly aging demographics. This trend is further fueled by increased awareness about the availability and success rates of corneal transplants, as well as advancements in surgical techniques that offer better outcomes and faster recovery times for older patients. As a result, the growing geriatric population is a major factor driving the expansion of the North America corneal transplant market, highlighting the need for accessible and effective treatment options for age-related corneal diseases.

Opportunity

• Rise in Healthcare Infrastructure

The rise in healthcare infrastructure offers significant opportunities for the North America corneal transplant market by expanding access to transplant services. Enhanced infrastructure leads to the establishment of more hospitals and specialized clinics, making corneal transplants more accessible to a broader population. Improved facilities in underserved or rural areas ensure that patients who previously had limited access to specialized eye care can now receive essential transplant services.

Modernized healthcare facilities are equipped with advanced surgical technologies and diagnostic tools, which directly improve the success rates of corneal transplants and minimize complications. Specialized centers within these advanced systems provide focused expertise and resources, further enhancing surgical outcomes and patient care. The increased capacity of these facilities also supports a higher volume of transplant procedures, effectively addressing patient demand and reducing waiting times.

 For instance,

• In April 2024, according to the article ‘The Rise of Hospital Infrastructure & Modernization Updates,’ the U.S. boasts of a robust healthcare infrastructure consisting of over 6,000 hospitals and thousands of small clinics, offering more than a million hospital beds to patients. This infrastructure encompasses a variety of essential elements, such as advanced research labs, cutting-edge technology, and a wide range of medical equipment. Moreover, the federal government has been providing funds for the continuous modernization of the country’s healthcare infrastructure
• In August 2023, according to JLL India, India has been welcoming more investments and innovation to deal with future life-threatening diseases and pandemics that, in turn, help in growing the country’s healthcare and life sciences sector

Restraint/Challenge

• The High Cost of Corneal Transplant Surgery

The high cost of corneal transplant surgery acts as a significant restraint on the growth of the North America corneal transplant market by limiting patient access and affordability, particularly in low- and middle-income countries. Corneal transplant procedures, including traditional Penetrating Keratoplasty (PK) and advanced techniques like Descemet’s Membrane Endothelial Keratoplasty (DMEK) or Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK), often involve substantial expenses not only for the surgical procedure itself but also for the associated costs of preoperative assessments, postoperative care, medications, and follow-up visits. Also, the cost of obtaining donor corneas, whether through eye banks or commercial sources, further contributes to the financial burden. In many regions, particularly those with limited healthcare infrastructure, these costs are exacerbated by a lack of insurance coverage or inadequate reimbursement policies, making corneal transplants financially inaccessible to a large portion of the population. Furthermore, the need for specialized surgical expertise and advanced equipment increases the overall expense, thereby restricting the availability of these procedures to well-equipped medical centers in urban areas. Consequently, the high costs associated with corneal transplant surgery hinder market growth by reducing the potential patient pool, especially in underserved regions where the burden of corneal diseases is often most significant and access to affordable healthcare is limited.

Recent Developments

• In January 2024, Carl Zeiss India's Medical Technology Division showcased Cataract and Refractive Workflow at Phaco Festival by Nethradhama Super Speciality, Bengaluru. At the Phaco Festival, the spotlight shined on ZEISS's transformative impact on the Cataract and Corneal Refractive Workflows.
• In June 2024, CorneaGen today announces the commercial launch of Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes. Developed by CorneaGen in partnership with CTAK LLC and Ziemer, CTAK provides patient ready, gamma-irradiated sterile, non-immunogenic corneal tissue segments, laser cut and customized to patients’ specific cone severity and location
• In January 2024, Seattle-based CorneaGen is excited to announce an expansion of their eye recovery services throughout northern and southern California. Through this expansion of service, CorneaGen will now provide both eye recovery and processing services of donor tissue for facilities throughout the state, resulting in an even better experience for the patients, families, and staff of their California partner facilities.
• In August 2024, ZEISS extends its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; ZEISS announces first treatment in the CE market for hyperopia with lenticule extraction using ZEISS SMILE pro technology

North America Corneal Transplant Market Scope

The North America corneal transplant market is segmented into eight notable segments based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

Procedure Type

• Endothelial Keratoplasty
•  Penetrating Keratoplasty
•  Anterior Lamellar Keratoplasty (ALK)
•  Corneal Limbal Stem Cell Transplant
•  Artifical Cornea Transplant
•  Others

On the basis of procedure type, the market is segmented into endothelial keratoplasty, penetrating keratoplasty, Anterior Lamellar Keratoplasty (ALK), corneal limbal stem cell transplant, artifical cornea transplant and others.

Type

• Human Cornea
• Synthetic

On the basis of type, the market is segmented into human cornea and synthetic.

Donor Type

• Allograft
• Autograft

On the basis of donor type, the market is segmented into allograft and autograft.

Graft Type

• Partial Thickness Grafts (Lamellar)
• Full Thickness Grafts (Penetrating)

On the basis of graft type, the market is segmented into partial thickness grafts (lamellar), full thickness grafts (penetrating).

Surgery Type

• Conventional Surgery
• Laser-Assisted Surgery

On the basis of surgery type, the market is segmented into conventional surgery and laser-assisted surgery.

Indication

• Fuch's Endothelial Dystrophy
•  Infectious Keratitis
•  Bullous Keratopathy
•  Keratoconus
•  Regraft Procedures
•  Corneal Scarring
•  Corneal Ulcers
•  Others

On the basis of indication, the market is segmented into fuch's endothelial dystrophy, infectious keratitis, bullous keratopathy, keratoconus, regraft procedures, corneal scarring, corneal ulcers and others.

Gender

• Female
• Male

On the basis of gender, the market is segmented into female and male.

Age Group

• Geriatric
•  Adult
•  Pediatric

On the basis of age group, the market is segmented into geriatric, adult and pediatric.

End User

• Hospitals,
• Eye Clinics,
•  Ambulatory Surgical Centers,
•  Academic & Research Institutes
• Others

On the basis of end user, the market is segmented into hospitals, eye clinics, ambulatory surgical centers, academic & research institutes and others.

North America Corneal Transplant Market Regional Analysis/Insights

North America corneal transplant market is analyzed, and market size insights and trends are provided based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user as referenced above.

The countries covered in this market report are U.S., Canada, and Mexico.

North America is expected to dominate the market due to factors like high prevalence of infections, advanced healthcare infrastructure, strong consumer awareness and purchasing power, ongoing research and development initiatives, established marketing and distribution networks

The U.S. is expected to dominate in the North America market due to factors such as large population, high healthcare expenditure, sophisticated healthcare system, extensive pharmaceutical industry, and widespread consumer awareness.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and North America Corneal Transplant Market Share Analysis

The North America corneal transplant market is segmented into eight notable segments based on procedure type, donor type, graft type, surgery type, indication, gender, age group, and end user.

يقدم المشهد التنافسي لسوق زراعة القرنية في أمريكا الشمالية تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور الإقليمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات على سوق زراعة القرنية في أمريكا الشمالية.

بعض اللاعبين الرئيسيين العاملين في سوق زراعة القرنية في أمريكا الشمالية هم ZEISS Group (Carl Zeiss Meditec AG.)، و Alcon، و CorneaGen، و Ziemer Ophthalmic Systems AG، و RUMEX International Co.، وغيرها.

SKU-72890